260 related articles for article (PubMed ID: 11815318)
1. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women.
Fohr IP; Prinz-Langenohl R; Brönstrup A; Bohlmann AM; Nau H; Berthold HK; Pietrzik K
Am J Clin Nutr; 2002 Feb; 75(2):275-82. PubMed ID: 11815318
[TBL] [Abstract][Full Text] [Related]
2. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
D'Angelo A; Coppola A; Madonna P; Fermo I; Pagano A; Mazzola G; Galli L; Cerbone AM
Thromb Haemost; 2000 Apr; 83(4):563-70. PubMed ID: 10780318
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients.
Bostom AG; Shemin D; Gohh RY; Beaulieu AJ; Bagley P; Massy ZA; Jacques PF; Dworkin L; Selhub J
Kidney Int Suppl; 2001 Feb; 78():S246-52. PubMed ID: 11169020
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinaemia, folate and vitamin B12 in unsupplemented haemodialysis patients: effect of oral therapy with folic acid and vitamin B12.
Billion S; Tribout B; Cadet E; Queinnec C; Rochette J; Wheatley P; Bataille P
Nephrol Dial Transplant; 2002 Mar; 17(3):455-61. PubMed ID: 11865092
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial.
Ashfield-Watt PA; Pullin CH; Whiting JM; Clark ZE; Moat SJ; Newcombe RG; Burr ML; Lewis MJ; Powers HJ; McDowell IF
Am J Clin Nutr; 2002 Jul; 76(1):180-6. PubMed ID: 12081832
[TBL] [Abstract][Full Text] [Related]
6. Supplementation with [6S]-5-methyltetrahydrofolate or folic acid equally reduces plasma total homocysteine concentrations in healthy women.
Lamers Y; Prinz-Langenohl R; Moser R; Pietrzik K
Am J Clin Nutr; 2004 Mar; 79(3):473-8. PubMed ID: 14985224
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study.
Venn BJ; Green TJ; Moser R; Mann JI
Am J Clin Nutr; 2003 Mar; 77(3):658-62. PubMed ID: 12600857
[TBL] [Abstract][Full Text] [Related]
8.
Huang X; Qin X; Yang W; Liu L; Jiang C; Zhang X; Jiang S; Bao H; Su H; Li P; He M; Song Y; Zhao M; Yin D; Wang Y; Zhang Y; Li J; Yang R; Wu Y; Hong K; Wu Q; Chen Y; Sun N; Li X; Tang G; Wang B; Cai Y; Hou FF; Huo Y; Wang H; Wang X; Cheng X
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):679-685. PubMed ID: 29371246
[TBL] [Abstract][Full Text] [Related]
9. The C677T MTHFR genotypes influence the efficacy of B9 and B12 vitamins supplementation to lowering plasma total homocysteine in hemodialysis.
Achour O; Elmtaoua S; Zellama D; Omezzine A; Moussa A; Rejeb J; Boumaiza I; Bouacida L; Rejeb NB; Achour A; Bouslama A
J Nephrol; 2016 Oct; 29(5):691-8. PubMed ID: 26559681
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine lowering by folate-rich diet or pharmacological supplementations in subjects with moderate hyperhomocysteinemia.
Zappacosta B; Mastroiacovo P; Persichilli S; Pounis G; Ruggeri S; Minucci A; Carnovale E; Andria G; Ricci R; Scala I; Genovese O; Turrini A; Mistura L; Giardina B; Iacoviello L
Nutrients; 2013 May; 5(5):1531-43. PubMed ID: 23698160
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins.
Tremblay R; Bonnardeaux A; Geadah D; Busque L; Lebrun M; Ouimet D; Leblanc M
Kidney Int; 2000 Aug; 58(2):851-8. PubMed ID: 10916110
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of folinic versus folic acid for the correction of hyperhomocysteinemia in hemodialysis patients.
Hauser AC; Hagen W; Rehak PH; Buchmayer H; Födinger M; Papagiannopoulos M; Bieglmayer C; Apsner R; Köller E; Ignatescu M; Hörl WH; Sunder-Plassmann G
Am J Kidney Dis; 2001 Apr; 37(4):758-65. PubMed ID: 11273876
[TBL] [Abstract][Full Text] [Related]
13. Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR (C677T) genotype.
Moat SJ; Ashfield-Watt PA; Powers HJ; Newcombe RG; McDowell IF
Clin Chem; 2003 Feb; 49(2):295-302. PubMed ID: 12560354
[TBL] [Abstract][Full Text] [Related]
14. [6S]-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C-->T polymorphism of methylenetetrahydrofolate reductase.
Prinz-Langenohl R; Brämswig S; Tobolski O; Smulders YM; Smith DE; Finglas PM; Pietrzik K
Br J Pharmacol; 2009 Dec; 158(8):2014-21. PubMed ID: 19917061
[TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages.
Nelen WL; Blom HJ; Thomas CM; Steegers EA; Boers GH; Eskes TK
J Nutr; 1998 Aug; 128(8):1336-41. PubMed ID: 9687553
[TBL] [Abstract][Full Text] [Related]
16. Controlled comparison of L-5-methyltetrahydrofolate versus folic acid for the treatment of hyperhomocysteinemia in hemodialysis patients.
Bostom AG; Shemin D; Bagley P; Massy ZA; Zanabli A; Christopher K; Spiegel P; Jacques PF; Dworkin L; Selhub J
Circulation; 2000 Jun; 101(24):2829-32. PubMed ID: 10859289
[TBL] [Abstract][Full Text] [Related]
17. Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia.
Ambrosino P; Lupoli R; Di Minno A; Nardo A; Marrone E; Lupoli V; Scaravilli A; Mitidieri E; Tufano A; Di Minno MN
Nutr Res; 2015 Jun; 35(6):489-95. PubMed ID: 25841618
[TBL] [Abstract][Full Text] [Related]
18. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.
Malinow MR; Nieto FJ; Kruger WD; Duell PB; Hess DL; Gluckman RA; Block PC; Holzgang CR; Anderson PH; Seltzer D; Upson B; Lin QR
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1157-62. PubMed ID: 9194768
[TBL] [Abstract][Full Text] [Related]
19. Effect of the methylenetetrahydrofolate reductase 677C-->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample.
de Bree A; Verschuren WM; Bjørke-Monsen AL; van der Put NM; Heil SG; Trijbels FJ; Blom HJ
Am J Clin Nutr; 2003 Mar; 77(3):687-93. PubMed ID: 12600862
[TBL] [Abstract][Full Text] [Related]
20. The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene.
Jacques PF; Kalmbach R; Bagley PJ; Russo GT; Rogers G; Wilson PW; Rosenberg IH; Selhub J
J Nutr; 2002 Feb; 132(2):283-8. PubMed ID: 11823591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
